Canaccord Genuity maintained a Hold rating on ResMed (NYSE: RMD) and raised its price target to $40.00 (from $36.00).

This article: 100 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE